Plasma 4β-Hydroxycholesterol Predicts Ribociclib CYP3A-Mediated Metabolism, but Not Plasma Exposure, in Patients with Primary Brain Cancer.

Kisqali (ribociclib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42649978

Charuka Wickramasinghe; Jing Li; Jun Jiang; Nader Sanai; Xun Bao; Yang Yue; Yuanyuan Jiang

Aug 28, 2026